blindness from glp-1 NAION Vision Loss Lawsuit Do GLP-1 medications cause blindness?,

GLP-1 Clinical Practice Updates: August 2025 Key Developments August 2025 delivered significant clinical practice updates that advance the GLP-1 treatment landscape, including the first generic approval, expanded FDA indications, and major oral therapy breakthroughs

The effects of GLP-1 RA delivery strategies on product efficacy and safety Different modification strategies not only affect the pharmacokinetic profiles of GLP-1 RAs but also strongly influence their efficacy, safety profile and usability

prophylactic measures in high-risk individuals may be considered [8,9]

Nat Rev Nephrol 12(2):7381 Muskiet MHA, Tonneijck L, Smits MM, Kramer MHH, Heerspink HJL, van Raalte DH (2015) Pleiotropic effects of type 2 diabetes management strategies on renal risk factors